# Study of DS-1001b in Patients With Gene IDH1-Mutated Gliomas

> **NCT03030066** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Daiichi Sankyo** · enrollment: 47 (actual)

## Conditions studied

- Glioma

## Interventions

- **DRUG:** DS-1001b

## Key facts

- **NCT ID:** NCT03030066
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-01-19
- **Primary completion:** 2021-01-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03030066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03030066, "Study of DS-1001b in Patients With Gene IDH1-Mutated Gliomas". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT03030066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*